Mail Stop 4-6 								April 20, 2005 Francis F. Lee President and Chief Executive Officer 2381 Bering Drive San Jose, CA 95131 	Re: 	Synaptics, Inc. 		Amendment No. 1 to Registration Statement on Form S-3 		Filed on March 31, 2005 		File No. 333-122348 Dear Mr. Lee: We have reviewed your responses and have the following comments. 1. We are in receipt of your request for confidential treatment of Exhibit 10.22 filed in a Form 8-K on April 1, 2005. We will provide comments on the confidential treatment request, if any, in a separate letter. Please note that the confidential treatment request must be processed before effectiveness of the registration statement. 2. See prior comment 4. We note your revision to footnote 6 to the selling securityholder table indicating that Bear, Stearns & Co. and KBC Financial Products USA "may be deemed to be, under the interpretations of the Securities and Exchange Commission," underwriters. Please revise to state unambiguously here and in the plan of distribution on page 77 that these broker-dealer selling shareholders are underwriters. 3. See prior comment 7. Please revise to incorporate the Item 1.01 Form 8-K filed April 1, 2005 and any other periodic reports "filed" prior to effectiveness. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filings reviewed by the staff to be certain that they have provided all information investors require for an informed decision. Since the company and its management are in possession of all facts relating to a company`s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. Any questions should be directed to Maryse Mills-Apenteng at (202) 942-1861. In her absence please contact the undersigned at (202) 942-1800. 								Sincerely, 								Barbara C. Jacobs 			Assistant Director cc: 	Via facsimile: 602-445-8603 	Brian Blaney, Esq. 	Greenberg Traurig, LLP ?? ?? ?? ?? Synaptics, Inc. April 20, 2005 Page 2 of 2